Study details
Enrolling now
Transcranial Ultrasound Stimulation (TUS) Trial
Sanmai Technologies PBC dba Sanmai
NCT IDNCT07207122ClinicalTrials.gov data as of Apr 2026
Target enrollment
20
Study length
about 11 months
Ages
18–80
Locations
1 site in CA
About this study
This trial is testing if transcranial ultrasound stimulation can improve neurological and cognitive function in people with Alzheimer's, Parkinson's, or other neurodegenerative diseases. The treatment involves using a device to stimulate specific areas of the brain.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Transcranial focused ultrasound modulation administered to a region involved in disease pathology
Primary goalBeck Depression Inventory
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Beck Depression Inventory, GAD-7
Secondary: Beck Depression Inventory, GAD-7
Body systems
Neurology